Knowledge and Attitudes toward New Disease-Modifying Treatments for Alzheimer's Disease among Nursing Home Directors
Abstract
Nursing home (NH) administrator perceptions regarding the utility of Alzheimer's disease (AD) disease-modifying medications in NHs are important because many short and long-stay residents have mild AD. This study examined the interest of directors of nursing (DoNs) in using new AD disease-modifying treatments, changes in attitudes based on differences in costs to the NH, and characteristics (DoN and NH) associated with such changes.
Publication Date
Winter 1-2025
Journal Title
ScienceDirect
Document Type
Article
Recommended Citation
Liang, S., Ott, B. R., Tjia, J., Lapane, K. L., Rataj, A. C., & Alcusky, M. (2024). Knowledge and attitudes toward new disease-modifying treatments for Alzheimer’s disease among nursing home directors. Journal of the American Medical Directors Association. Advance online publication.